Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

TrialReach Announces First Three Members of Advisory Board
  • USA - English


News provided by

Sparkpr

Jul 29, 2014, 11:00 ET

Share this article

Share toX

Share this article

Share toX

London, UK (PRWEB) July 29, 2014 -- TrialReach, the world’s largest provider of clinical research information and patient-clinical trial matching, today announced the company’s first three advisory board members: "e-patient Dave" deBronkart, Trae Vassallo, and Adam Dole. TrialReach is helping to solve one of the most challenging problems plaguing clinical trial research and development by enabling patients and researchers to connect with one another in order to advance the development of new drug treatments and therapies. The new advisory board members come from various backgrounds in innovation, technology and patient advocacy, and will provide guidance regarding the company's patient programs, strategic roadmap and technology innovations.

"Not enough patients know about or take part in the clinical research that could lead to faster cures," said TrialReach Chief Executive Officer, Pablo Graiver. "Our first three advisors share our commitment to solving this critical problem. We are very honored to have such talented and highly esteemed individuals working with us to break down the walls between patients and medical researchers and speed up the development of new treatments."

“e-Patient Dave” deBronkart, one of the world’s leading advocates for the role of informed patients, is TrialReach’s Special Advisor for Patient Perspective. A survivor of a near-fatal kidney cancer, Dave spent his career in high tech, observing disruption at close range as technology put power in consumer hands. With 25 years in online communities, he knows end users see things differently and developers optimize better when they align with the consumer’s view.

“Patients know what patients want to know,” he said, quoting from his highly rated book Let Patients Help: A Patient Engagement Handbook. “And people perform better when they’re informed better.” As co-chair of the Society for Participatory Medicine, he says, “E-patients are empowered, engaged, equipped and enabled. Smart patients are driven by informed choice. The Institute of Medicine itself says medicine must be anchored on patient needs and perspectives – it doesn’t get more authoritative than that. TrialReach exists to get patients the access and information they deserve, to make informed decisions when their health is on the line.”

Trae Vassallo is an independent advisor and was most recently a General Partner at Kleiner Perkins Caufield and Byers, one of Silicon Valley’s most venerable venture capital firms. In addition to her many achievements and successes at Kleiner Perkins, Vassallo was instrumental in the firm’s early investment in Nest Labs, and led the Dropcam investment, which was recently acquired by Nest. Vassallo, who holds an MBA from Stanford Graduate School of Business and both Bachelor’s and Master’s degrees in mechanical engineering also from Stanford, owns 13 patents representing her extensive work in technology innovation. Prior to joining Kleiner Perkins in 2003 as an entrepreneur-in-residence, Vassallo worked for famed design studio, IDEO, where she designed products for Palm and Dell, and later co-founded the Kleiner-funded mobile software company, Good Technology, which was sold to Motorola in 2006.

"I am particularly drawn to opportunities where an understood transformative technology is applied to a new underserved market. Online marketplaces are not new, but this combination of using the reach of the web to democratize the clinical trial process is truly transformative," said Trae Vassallo, TrialReach advisory board member.

Adam Dole is a former Presidential Innovation Fellow at The White House who worked on the MyData Blue Button Initiative at the US Department of Health and Human Services. Previously, Dole was an entrepreneur-in-residence at the Mayo Clinic, where he developed new ventures at the intersection of healthcare and technology to expand Mayo Clinic’s scope and reach through new business models, including Better, a personal health assistant service based in Palo Alto, CA. Earlier in his career, Dole held positions at NASA’s human factors research division, Jump Associates and Method Inc.

“I am inspired by TrialReach's relentless commitment to putting the human element back into the clinical trial process. For many, the clinical trial process can be scary, intimidating and often focuses on the needs of the healthcare system rather than those of the patients,” said Adam Dole, TrialReach advisory board member. “By taking a patient-centric approach, TrialReach has a significant opportunity to differentiate its value proposition by meeting patients where they are and empowering them with a clinical trial experience that builds confidence, trust and increases self-efficacy, thereby, increasing the quality and longevity of people's lives.”

About TrialReach
TrialReach is using technology to solve one of the biggest problems in clinical trials, helping patients and researchers connect. Our mission is to empower millions of people to participate in clinical trials across the world to develop new medical treatments and find cures faster. TrialReach was launched in 2010 and is based in the US and London, UK. For more information, visit http://www.trialreach.com.

Media Contact
Sarah Kerruish
TrialReach
sarah(at)trialreach(dot)com
+44 (754) 636-4484

Rachel Kahn, Sparkpr, 415.321.1881, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.